BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/15/2025 3:58:01 AM | Browse: 175 | Download: 692
 |
Received |
|
2024-10-03 15:06 |
|
Peer-Review Started |
|
2024-10-03 15:06 |
|
First Decision by Editorial Office Director |
|
2024-11-25 10:38 |
|
Return for Revision |
|
2024-11-25 10:38 |
|
Revised |
|
2024-12-14 15:02 |
|
Publication Fee Transferred |
|
2024-12-17 04:51 |
|
Second Decision by Editor |
|
2024-12-26 02:35 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-12-27 10:29 |
|
Articles in Press |
|
2024-12-27 10:29 |
|
Edit the Manuscript by Language Editor |
|
2025-01-04 01:27 |
|
Typeset the Manuscript |
|
2025-01-13 01:26 |
|
Publish the Manuscript Online |
|
2025-01-15 03:58 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medical Informatics |
| Manuscript Type |
Case Report |
| Article Title |
Vitiligo-like rash in a patient with lung cancer caused by sintilimab: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiao-Ming Mao and Wei-Hua Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wei-Hua Wang, Department of Respiratory and Critical Care Medicine, Jiangshan People’s Hospital, No. 9 Hangbengshan Road, Jiangshan 324100, Zhejiang Province, China. mxm0077@163.com |
| Key Words |
Lung cancer; Vitiligo; Immune checkpoint inhibitor; Sintilimab; Case report |
| Core Tip |
The article presents a case study of a 63-year-old male with non-small cell lung cancer treated effectively with chemotherapy and immunotherapy, despite developing immune-related skin adverse events manifesting as a vitiligo-like rash. The treatment with sintilimab, a programmed death 1 inhibitor, resulted in tumor regression and highlighted the need for further research into the prognostic significance and mechanisms of vitiligo-like rash in lung cancer patients undergoing immunotherapy. |
| Publish Date |
2025-01-15 03:58 |
| Citation |
Mao XM, Wang WH. Vitiligo-like rash in a patient with lung cancer caused by sintilimab: A case report. World J Clin Cases 2025; 13(14): 101981 |
| URL |
https://www.wjgnet.com/2307-8960/full/v13/i14/101981.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v13.i14.101981 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
